Key TakeawaysRevvity reported second-quarter profit and sales that exceeded estimates on higher demand for its diagnostic products.The medical equipment maker posted a 1.4% year-over-year increase in revenue at its Diagnostics segment, while revenue at its Life Sciences division declined.Revvity raised its full-year adjusted EPS guidance. Revvity (RVTY) shares advanced Monday after the medical equipment maker formerly known as PerkinElmer posted better-than-expected results and boosted its profit guidance o ...